Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01746303 · ClinicalTrials.gov registry record · NA
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT01746303: Completed NA study, sponsored by University of Cincinnati.
NCT01746303 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 94 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01746303, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
The aim of this study is to determine the efficacy of 6 months' dietary supplementation with omega-3 fatty acids and whole freeze dried blueberry powder in improving cognition in older adults. The effects of each of these interventions alone will also be assessed in order to determine whether the combined treatment confers synergistic or additive benefit relative to the effect of each therapy.
Primary Outcome
The following tests will be administered to measure working memory function: * Porteus Maze Test * Verbal Primary Memory with Interference Test * Letter Number Sequencing Task * Controlled Oral Word Production Task
Interventions
- OTHER Placebo powder
- DIETARY_SUPPLEMENT Blueberry powder
- DIETARY_SUPPLEMENT Omega-3 fatty acid
- OTHER Placebo oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2010-01 |
| Est. Completion | 2016-01 |
| Phase | NA |
What the finished NCT01746303 record still lists
NCT01746303 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo powder is the first listed.
NCT01746303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01746303 about?
NCT01746303 is a clinical study titled "Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline". The aim of this study is to determine the efficacy of 6 months' dietary supplementation with omega-3 fatty acids and whole freeze dried blueberry powder in improving cognition in older adults. The effects of each of these interventions alone will also be assessed in order to determine whether the co...
What is the current status of trial NCT01746303?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2010-01. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01746303?
The interventions under investigation include: Placebo powder (OTHER), Blueberry powder (DIETARY_SUPPLEMENT), Omega-3 fatty acid (DIETARY_SUPPLEMENT), Placebo oil (OTHER).
Who is sponsoring clinical trial NCT01746303?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01746303's enrollment target sits among peer trials
94 935th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia